Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Richard Garchitorena maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $8...
Trump's warning to end business with China highlights food trade as ag-tech industries benefit and Chinese suppliers may be...
Argus Research analyst Alexandra Yates maintains Corteva (NYSE:CTVA) with a Buy and lowers the price target from $83 to $80.
Mizuho analyst John Roberts maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $85 to $78.
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Buy and lowers the price target from $91 to $85.
Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.
Keybanc analyst Aleksey Yefremov downgrades Corteva (NYSE:CTVA) from Overweight to Sector Weight.
